Kelly West Award for Outstanding Achievement in Epidemiology
Knut Borch-Johnsen, MD, PhD
The recipient of the Kelly West Award is Knut Borch-Johnsen, MD, PhD. Supported by an education grant from Merck, this award is given to an individual who has made significant contributions to the field of diabetes epidemiology.
Currently a professor and research director at the Research Center for Quality in Health Care, Institute of Public Health, University of Southern Denmark, Odense, Dr. Borch-Johnsen was the first to describe the relationship between proteinuria and mortality in type 1 diabetes, and the importance of proteinuria as a predictor of cardiovascular mortality in type 2 diabetes. He was a major contributor to the literature that led to consensus on the inclusion of HbA1c in the diagnostic criteria.
Dr. Borch-Johnsen initiated the DECODE and DECODE Asia study groups, which pooled results of epidemiological studies with longitudinal follow-up to quantify the relationship between states of glucose intolerance and cardiovascular disease. He organized the ADDITION Study, which involves thousands of people with screen-detected diabetes to determine whether early, aggressive treatment influences complication rates and mortality.
As director of the Steno Diabetes Center in Denmark and through his active participation in epidemiological training courses worldwide, Dr. Borch-Johnsen has helped educate young investigators about diabetes epidemiology. He has been active in the European Association for the Study of Diabetes, the European Diabetes Epidemiology Group, and the International Diabetes Epidemiology Group.